Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peyman Hadji

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Journal of Cancer Research and Clinical Oncology|November 26, 2013
Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trialMichaela Bossart, Peyman Hadji, Maximilian Klar, et al.
Nutrition Research (New York, N.Y.)|November 21, 2016
Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled interventionTina Heinz, Jan Philipp Schuchardt, Katharina Möller, et al.
Anticancer Research|September 21, 2012
Compliance, analgesic use and side-effect protection within a German cohort of the TEAM trialMichaela Bossart, Meike Becker, Peyman Hadji, et al.
International Journal of Clinical Oncology|May 11, 2012
Treatment of bone metastases before the onset of painLuis Costa, Allan Lipton, Peyman Hadji, et al.
Breast Cancer Research and Treatment|August 13, 2015
Impact of disease management programs on women with breast cancer in GermanyLouis Jacob, Peyman Hadji, Ute-Susann Albert, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 19, 2023
Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-upIoannis Kyvernitakis, Thea Charlott Reuter, Lars Hellmeyer, et al.
Bone|June 17, 2018
Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trialIoannis Kyvernitakis, Peter Herbert Kann, Friederike Thomasius, et al.
Archives of Osteoporosis|August 31, 2022
Real-world effectiveness of osteoporosis treatments in GermanyJames O'Kelly, Robert Bartsch, Nils Kossack, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 28, 2012
Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal womenMay Ziller, Julia Herwig, Volker Ziller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 2, 2024
Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER<sup>®</sup> and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture riskPeyman Hadji, Luka Kamali, Friederike Thomasius, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Journal of Cancer Research and Clinical Oncology|November 26, 2013
Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trialMichaela Bossart, Peyman Hadji, Maximilian Klar, et al.
Nutrition Research (New York, N.Y.)|November 21, 2016
Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled interventionTina Heinz, Jan Philipp Schuchardt, Katharina Möller, et al.
Anticancer Research|September 21, 2012
Compliance, analgesic use and side-effect protection within a German cohort of the TEAM trialMichaela Bossart, Meike Becker, Peyman Hadji, et al.
International Journal of Clinical Oncology|May 11, 2012
Treatment of bone metastases before the onset of painLuis Costa, Allan Lipton, Peyman Hadji, et al.
Breast Cancer Research and Treatment|August 13, 2015
Impact of disease management programs on women with breast cancer in GermanyLouis Jacob, Peyman Hadji, Ute-Susann Albert, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 19, 2023
Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-upIoannis Kyvernitakis, Thea Charlott Reuter, Lars Hellmeyer, et al.
Bone|June 17, 2018
Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trialIoannis Kyvernitakis, Peter Herbert Kann, Friederike Thomasius, et al.
Archives of Osteoporosis|August 31, 2022
Real-world effectiveness of osteoporosis treatments in GermanyJames O'Kelly, Robert Bartsch, Nils Kossack, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 28, 2012
Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal womenMay Ziller, Julia Herwig, Volker Ziller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 2, 2024
Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER<sup>®</sup> and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture riskPeyman Hadji, Luka Kamali, Friederike Thomasius, et al.
Pageof 18